Arcutis Biotherapeutics Inc (ARQT)

Stock-Based Compensation

$12.76M

Quarterly · Period ending: · USD

ARQT logo

ARQT Stock-Based Compensation

Latest reported$12.76M
ARQT Quarterly Stock-Based Comp ($21.00K → $12.76M)
High-resolution chart · PNG

ARQT stock-based compensation history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Arcutis Biotherapeutics Inc Stock-Based Compensation — Quarterly (USD)
Period endingStock-Based Compensation (USD)
12,762,000
10,690,000
10,060,000
10,037,000
10,489,000
9,778,000
9,393,000
9,784,000
12,523,000
10,030,000
8,757,000
9,999,000
10,578,000
9,479,000
9,264,000
8,789,000
8,096,000
6,533,000
5,686,000
5,363,000
4,340,000
8,503,000
2,643,000
0
2,049,000
990,000
455,000
154,000
139,000
76,000
56,000
53,000
21,000
21,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.